[Form 4] SHERWIN WILLIAMS CO Insider Trading Activity

Rhea-AI Filing Summary

Sherwin-Williams (SHW)16,920 shares at an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.

The options vest annually in three substantially equal installments commencing October 20, 2026, and carry an expiration date of October 19, 2035. Following the reported transaction, the reporting person holds 16,920 derivative securities directly.

10/22/2025 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mistysyn Allen J

(Last) (First) (Middle)

101 W. PROSPECT AVENUE

(Street)

CLEVELAND OH 44115

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP - Finance & CFO

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$331.37	10/20/2025		A		16,920		(1)	10/19/2035	Common Stock	16,920	$0	16,920(1)	D

Explanation of Responses:

1. These options were granted on October 20, 2025, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sherwin-Williams (SHW) disclose on this Form 4?

An employee stock option grant to the SVP–Finance & CFO for 16,920 shares at an exercise price of $331.37 per share.

How many Sherwin-Williams options were granted and at what price?

The grant was for 16,920 options with an exercise price of $331.37 per share.

When do the SHW options vest for the CFO?

They vest annually in three substantially equal installments commencing October 20, 2026.

What is the expiration date of the SHW options?

The options expire on October 19, 2035.

What plan governs the option grant?

The grant was made under Sherwin-Williams’ 2025 Equity and Incentive Compensation Plan.

How many derivative securities does the reporting person own after the transaction?

The reporting person beneficially owns 16,920 derivative securities directly following the transaction.

Who signed the filing for the reporting person?

It was signed by Stephen J. Perisutti, attorney-in-fact, on October 22, 2025.